Naloxone Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIDA
|
2011
|
|
Nanomaterial Registry
|
Resource Development
|
FDA
|
NCI, NIBIB, NIEHS
|
2010
|
|
Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
2004
|
|
National Asthma Control Initiative (NACI)/National Asthma Education and Prevention Program (NAEPP)
|
Public Education Campaign
|
CDC, FDA
|
NHLBI, NIAID, NIEHS
|
2008
|
|
National Asthma Education and Prevention Program Federal Liaison Group on Asthma (FLGA)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR
|
1998
|
|
National Asthma Education and Prevention Program Federal Liaison Group on Asthma (FLGA)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR
|
1998
|
|
National Asthma Education and Prevention Program Federal Liaison Group on Asthma (FLGA)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR
|
1998
|
|
National Blood Disorders Program
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIMHD
|
2011
|
|
National Clinical Trials Network (NCTN) Scientific Steering Committees
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2008
|
|
National Food and Nutrient Analysis Program (NFNAP)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, IHS
|
NCI, NEI, NHLBI, NIA, NICHD, NIDDK, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ORWH
|
1997
|
|
National Health and Nutrition Examination Survey (NHANES)
|
Health Survey
|
CDC, FDA, OS
|
NCI, NHLBI, NIA, NIDDK, OD/ DPCPSI, OD/ DPCPSI/ ODP
|
1999
|
|
National Interagency Confederation for Biological Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIAID
|
2002
|
|
National Kidney Disease Education Program
|
Public Education Campaign
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NHLBI, NIDDK
|
1998
|
|
National Partnership for Action to End Health Disparities (NPA): Federal Interagency Health Equity Team (FIHET)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCATS, NCI, NCMHD, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIMH, NIMHD, NINR, OD/ DPCPSI/ ODP
|
2006
|
|
National Partnership for Action to End Health Disparities (NPA): Federal Interagency Health Equity Team (FIHET)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCATS, NCI, NCMHD, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINR, OD/ DPCPSI/ ODP
|
2006
|
|
National Robotics Initiative
|
Research Initiative
|
FDA
|
NEI, NIA, NIBIB, NICHD, NIDCD, NINDS, NINR
|
2009
|
|
National Security Staff Combatting Antibiotic-Resistant Bacteria sub-Interagency Policy Committee (NSS CARB sub-IPC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NLM, OD/ OSP
|
2014
|
|
National Toxicology Program (NTP) Executive Committee
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC, FDA
|
NCI, NIEHS
|
1985
|
|
NCI Clinical Trials and Translational Research Advisory Committee (CTAC)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCI
|
2007
|
|
NCI National Cancer Informatics Program (NCIP) Nanotechnology Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NHLBI, NIBIB, NIEHS
|
2008
|
|
NCI/FDA Federal Investigator Registry of Biomedical Information Research Data (FIREBIRD)
|
Resource Development
|
FDA
|
NCI
|
2004
|
|
NCI/FDA Memorandum of Understanding for Drug Related Information
|
Resource Development
|
FDA
|
NCI
|
2012
|
|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
NCI
|
2007
|
|
Neural Interfaces Conference
|
Meeting/ Workshop
|
FDA
|
CSR, NEI, NIA, NIBIB, NICHD, NIDCD, NINDS
|
2006
|
|
Newborn Drug Development Planning Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI, NICHD, NLM
|
2011
|
|
Newborn Screening Pompe Pilot Study
|
Research Initiative
|
CDC, FDA, HRSA
|
NICHD
|
2014
|
|
NHLBI Federal COPD Workshop
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, CMS, FDA, HRSA, IHS
|
NCCAM, NHLBI
|
2013
|
|
Nicotine Research Cigarettes (SPECTRUM)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA
|
2013
|
|
NIH / FDA interagency partnership to foster tobacco regulatory research
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA
|
2012
|
|
NIH Biomarkers Consortium
|
Research Initiative
|
CMS, FDA
|
NCI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDDK, NIMH, NINDS
|
2006
|
|
NIH Guide for Grants and Contracts
|
Resource Development
|
AHRQ, CDC, FDA
|
CC, CIT, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OER
|
2007
|
|
NIH Recombinant DNA Advisory Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NHGRI, NIAID, NINDS, OD/ OSP
|
1974
|
|
NIH Translational Research Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, CIT, CSR, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OER, OD/ OIR, OD/ OSP
|
2008
|
|
NIH-FDA Interagency Clinical Outcome Assessment Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NCI, NEI, NHLBI, NIA, NIAMS, NICHD, NIDDK, NIMH, NINDS, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ORWH
|
2010
|
|
NIH-FDA Joint Leadership Council
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCATS, NCI, NHLBI, NIAID, NIDDK, NIMH, NINDS, OD/ OSP
|
2010
|
|
NIH-FDA Tobacco Regulatory Science Workgroup and Member Tobacco Training Workgroup subgroup
|
Research Initiative
|
FDA
|
NCI, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
NIH-FDA Tobacco Regulatory Science Workgroup, Tobacco Training Workgroup subgroup
|
Research Initiative
|
FDA
|
NCI, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
NNI Nanotechnology Signature Initiative on Nanotechnology for Sensors and Sensors for Nanotechnology: Improving and Protecting Health, Safety, and the Environment
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB
|
2012
|
|
NNI Nanotechnology Signature Initiative on Nanotechnology Knowledge Infrastructure: Enabling National Leadership in Sustainable Design
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB
|
2012
|
|
North American Plan For Animal and Pandemic Influenza
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
Novel Vaccines and Poliomyelitis Disease
|
Meeting/ Workshop
|
CDC, FDA
|
FIC
|
2014
|
|
Nutrition Coordinating Committee (NCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, OS
|
CC, CIT, CSR, FIC, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR
|
1975
|
|
|